Provasculon
Latest round
- Series A
Last raised
- Mar 2008
Total raised
- $6M
Investors
- 2
About Provasculon
Founded in 2007 and based in Massachusetts, US, Provasculon, Inc. is a biotechnology company that develops novel forms of stromal cell-derived therapeutic proteins to treat patients with cardiovascular diseases and diabetic ulcers.
Who invested in Provasculon
2 investors across 1 round
See all investors in Provasculon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 20, 2008
Amount
$6M
Investors
Questions about Provasculon
Who invested in Provasculon?
Provasculon has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Provasculon raised?
Provasculon has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Provasculon last raise money?
Provasculon's most recent round on record is a Series A, in Mar 2008.
What does Provasculon do?
Founded in 2007 and based in Massachusetts, US, Provasculon, Inc.
Where is Provasculon headquartered?
Provasculon is headquartered in Cambridge, US.
Which VCs invest in companies like Provasculon?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Provasculon's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Provasculon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.